Detalles de la búsqueda
1.
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria.
Lancet Rheumatol;
6(7): e460-e468, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824935
2.
Celebrating progress in the vasculitides, old and new.
Lancet Rheumatol;
6(5): e263-e265, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38574741
3.
Fibrotic phenotype of IgG4-related disease.
Lancet Rheumatol;
6(7): e469-e480, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38574746
4.
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States.
Rheumatology (Oxford);
2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637947
5.
Multimodality Imaging Features of Immunoglobulin G4-related Vessel Involvement.
Radiol Cardiothorac Imaging;
6(2): e230105, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483247
6.
Diagnosis and management of ANCA-associated vasculitis.
Lancet;
403(10427): 683-698, 2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368016
7.
Qualitative interviews to support development of a patient-reported companion measure to the Glucocorticoid Toxicity Index.
J Neurol Sci;
458: 122907, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309251
8.
Granzyme K- and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease.
J Allergy Clin Immunol;
153(4): 1095-1112, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092138
9.
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Rheumatol Ther;
10(6): 1795-1808, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792260
10.
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis.
Arthritis Res Ther;
25(1): 199, 2023 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840134
11.
Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index.
Semin Arthritis Rheum;
63: 152253, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619485
12.
Eosinophilic Angiocentric Fibrosis of the Orbit: A Clinicopathologic Review of 6 Novel Cases With Review of the Literature.
Am J Ophthalmol;
256: 9-19, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37495006
13.
Extrafollicular IgD-CD27-CXCR5-CD11c- DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19.
Cell Rep;
42(6): 112630, 2023 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300833
14.
Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report.
Front Neurol;
14: 1189778, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37292126
15.
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults.
Ann Rheum Dis;
82(7): 957-962, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137671
16.
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.
RMD Open;
9(2)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024237
17.
Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality.
Arthritis Rheumatol;
75(9): 1599-1607, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37011036
18.
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
RMD Open;
9(1)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990659
19.
IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement.
Semin Arthritis Rheum;
60: 152184, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36848823
20.
Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Arthritis Care Res (Hoboken);
75(9): 1976-1985, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645017